Advertisement

Apellis Pharmaceuticals, Inc. APLS

Set alert

Price alert · APLS

All alert types
41.03 USD 0.00 0.00%

At close · May 15

41.06 +0.03 +0.07%

After hours · May 15, 4:00 PM ET

Bid
41.04 × 14
Ask
41.05 × 1
41.03 Day range 41.05
16.83 52-week range 41.14
YTD
+63.34%
1 year
+150.79%
Open
41.05
Prev close
41.03
Mkt cap
5.25B
Vol
28.64M
Avg vol
7.54M
EPS
1.02
P/E
38.71
Div yield
0.00%
More statistics
Low
41.03
High
41.05
Beta
-0.25
Inst. own
110.43%
Dividend
0.00
Earnings
Jul 30, 2026

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for APLS has not been loaded yet. Try again in a moment.

Revenue & Expenses

Revenue by
Product → Revenue: $192.01MRevenue → Gross Profit: $227.46MGross Profit → Net Income: $18.66MGross Profit → Selling, General & Admin: $124.32MGross Profit → Research & Development: $76.96MRevenue → Cost of Revenue: $40.84MGross Profit → Other Expenses: $7.02MGross Profit → Income Tax: $496.00KLicensing And Other Revenue → Revenue: $76.28MGross Profit$227.46MCost of Revenue$40.84MNet Income$18.66MSelling, General & Admin$124.32MResearch & Development$76.96MOther Expenses$7.02MIncome Tax$496.00KRevenue$268.30MProduct$192.01MLicensing And Other Revenue$76.28M

Period ending Mar 31, 2026 · select a line to chart its history

Income statement

APLS quarterly income statement
268.30M
268.30M
40.55M
227.75M
201.28M
76.96M
124.32M
26.47M
10.32M
496.00K
18.66M
18.66M
18.66M
18.66M
0.15
0.15
0.15
29.47M
29.47M
127.68M
131.42M

Balance sheet

APLS quarterly balance sheet
406.73M
406.73M
440.30M
1.03B
20.36M
1.08B
100.71M
475.76M
283.45M
375.05M
667.61M
-2.99B
-2.41M
414.92M
414.92M
54.51M
475.76M
159.90M
384.16M
49.05M

Cash flow

APLS quarterly cash flow
291.00K
64.00K
-61.03M
86.00K
-60.97M
-131.00K
25.17M
Advertisement